Binex Co

Binex Co Interest Coverage

The Interest Coverage Ratio of Binex Co (053030.KQ) as of Oct 27, 2026 is -4.66. In the previous year, Interest Coverage Ratio was 4.60 — a change of -201.15% (lower).

Interest Coverage

-4.66

YoY

-201.15%

Last updated:

Interest Coverage Ratio of Binex Co is 2024 -4.66 . Interest Coverage Ratio of Binex Co was 2023 4.60 . It decreases by -201.15% lower compared to the previous year.

The Binex Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
-4.57 KRW
Jan 1, 2018
4.27 KRW
Jan 1, 2019
8.65 KRW
Jan 1, 2020
0.77 KRW
Jan 1, 2021
1.10 KRW
Jan 1, 2022
8.03 KRW
Jan 1, 2023
4.60 KRW
Jan 1, 2024
-4.66 KRW
The Binex Co Interest Coverage history
YEARInterest CoverageYoY
-4.66-201.15%
4.60-42.63%
8.03+630.75%
1.10+43.40%
0.77-91.14%
8.65+102.50%
4.27-193.48%
-4.57+108.62%
-2.19-27.77%
-3.03-1,436.43%
0.23—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Binex Co Stock analysis

What does Binex Co do? Binex Co Ltd generates revenue through the manufacturing and sale of pharmaceutical products including digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal tract regulators, antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, and various ointments and creams. The company also produces bio medicines and raw materials. Binex Co Ltd distributes its products domestically within Busan and to overseas markets, targeting healthcare providers, pharmacies, and hospitals that purchase pharmaceuticals for patient care and treatment. The firm's product portfolio covers a wide range of therapeutic areas, including gastrointestinal health, cardiovascular support, pain management, respiratory care, and chronic disease management. By offering both branded and generic pharmaceutical solutions, Binex Co Ltd serves diverse customer segments across the domestic and international pharmaceutical markets, leveraging its manufacturing capabilities to meet regional healthcare demands. Binex Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Binex Co stock

Interest Coverage Ratio of Binex Co is -4.66 in 2024.

Interest Coverage Ratio of Binex Co changed from 4.60 to -4.66, representing a -201.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Binex Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Binex Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Binex Co

All Key Metrics — Binex Co